verified COP 1,9 · Q3 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q3 — Biochemistry (medical) lock Subscription

Biomarkers in Medicine

Biomarkers in Medicine is a journal indexed in SJR in Drug Discovery and Biochemistry (medical) with an H index of 59. It has a COP Index of 1,9 (best band Q3). It has a COP Index of 1,9.

Biomarkers in Medicine focuses its scope in these topics and keywords: pharmacogenomic, clinical, function, era, therapy, factors, triage, making, genome, causal, ...

ISSN: 1752-0363

Publisher: Taylor and Francis Ltd.

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

COP Index trending_up

1,9 Q3

30 of 55 journals in Biochemistry (medical)

H-index · SJR 59 · 0,493

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

1,9

SJR Impact

0,493

H-index

Docs (year)

110

Docs 3y

366

Total refs

4763

Cites 3y

622

Citable 3y

355

Cites/Doc 2y

1.82

Ref/Doc

43.3

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biomarkers of multiorgan injury in neonatal encephalopathy

Using biomarkers to detect oral cancer holds potential for saving lives when the cancer is most curable

Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients

Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results

Company Profile: Caprion Proteomics, Inc.

Companion diagnostics at the intersection of personalized medicine and healthcare delivery

Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis

Clinical characteristics and biomarkers analysis of asthma inflammatory phenotypes

Classical and new assays for detecting drug resistance in tuberculosis

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function

Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?

Book Review: Biomarkers in drug development: a handbook of practice, application and strategy

SHOW MORE ARTICLES

Biomarkers of susceptibility following benzene exposure: influence of genetic polymorphisms on benzene metabolism and health effects

A window into your heart: taking cardiac troponin to the next level

Biomarkers for understanding Ebola virus disease

Biomarkers for invasive aspergillosis: the challenges continue

Biomarkers for breast cancer stem cells: the challenges ahead

Biomarker tests for fetal lung maturity

Biomarker discovery for childhood infections: paving the way for a diagnostic revolution in the developing world

Beyond biomarkers: an opportunity to address the 'pharmacodynamic gap' in pediatric drug development

Association between polymorphisms of glutathioneS-transferase genes (GSTM1,GSTP1andGSTT1) and breast cancer risk in a sample Iranian population

Approaches to biomarkers in human colorectal cancer: looking back, to go forward

Applications of 'decisionable' biomarkers in cardiovascular drug development

Analytical aspects of molecular Alzheimer's disease biomarkers

FAQs

Biomarkers in Medicine has a COP Index of 1,9 (Q3), ranked 30 of 55 in Biochemistry (medical). SJR: 0,493.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Biomarkers in Medicine is 31%.

Biomarkers in Medicine

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the COP Index of Biomarkers in Medicine?

What is the APC / publication cost?

What is the acceptance rate?